the aid library

LIST OPTIONS

Filter

4834

Financing HIV Programming: How Much Should Low And Middle-Income Countries and their Donors Pay?

Galarraga, O.; V. J. Wirtz; Y. Santa-Ana-Tellez et al. PLOS One (2013) C1

Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t... more

External Link

When could new antiretrovirals be recommended for national treatment programmes in low-income and middle-income countries: results of a WHO Think Tank

M. Vitoriaa; N. Forda; P. Clayden; et al. Wolters Kluwer Health; World Health Organization (2017) C2

Review www.co-hivandaids.com Volume 12 􏰀 Number 4 􏰀 July 2017

Download (240)

View PDF (255)

Consenso de recomendaciones para el manejo ambulatorio y tratamiento domiciliario de pacientes con COVID-19 ( Version 1)

Segvia, E. V. L. et al. Ministerio de Salud Pública de Ecuador (2020) CC

Consensual recommendations for outpatient management and home care and home treatment of patients with COVID-19

Download (293)

View PDF (507)

HIVi/AIDSi ravi ja hooldus Eestis

D. Raben; S. F. Jakobsen; F. Nakagawa; et al. Maailma Terviseorganisatsioon (Euroopa); WHO Collaborating Centre on HIV and Viral Hepatitis; Centre for Health & Infectious Disease Research (CHIP) (2014) C_WHO

Hindamisaruanne Juuni 2014

External Link

Tuberculosis control in prisons: current situation and research gaps

M. Dara, C. D. Acosta, M. V. S. Vinklers Melchers, et al. International Journal of Infectious Diseases (2015) C2

International Journal of Infectious Diseases 32 (2015) 111–117

Download (270)

View PDF (410)

Clinical utlity of peptide microarrys in the serodiagnosis of neglected tropical diseases in sub-Saharan Africa: protocol for a diagnostic test accuracy sytematic review

Vengesai A., Naicker T., Kasambala M., et al. (2021) C2

BMJ Open 2021;11:e042279. doi:10.1136/bmjopen-2020-042279. Neglected tropical diseases tend to cluster in the same poor populations, and to make progress with their control, they will have to be dealt with in an integrated manner. Peptide microarrays may be a solution to tese problems, where diagnos... more

Download (500)

View PDF (586)

Miners

M. Smelyanskaya, J. Duncan (The Focus Group Consulting); D. Daniels, et al. Stop TB Partnership; UNOPS; END TB (2016) C1

Key popupations brief.

Download (275)

View PDF (295)

Developing and Operationalizing a National Monitoring and Evaluation System for the Protection, Care and Support of Orphans and Vulnerable Children Living in a World with HIV and AIDS

S. Laver; B. Noubary; et al. Unicef (2009) C_UNICEF

Guidance Document Unite for Children

Download (318)

View PDF (320)

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

External Link

2015 Pipeline Report HIV, Hepatitis C virus (HCV), and Tuberculosis (TB)

Polly Clayden, Simon Collins, Mike Frick, et al. A. Benzacar; HIV i-BASETREATMENT ACTION GROUP (2015)

Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development

External Link

H2P Community Planning and Response Curriculum. District and Community Leaders

Humanitarian Pandemic Preparedness (H2P) Initiative USAID; ICRC; CoreGroup; et al. (2009) CC

The Humanitarian Pandemic Preparedness (H2P) Initiative and its many partners have developed ready-to-use training curricula for district- and community-level leaders, and community volunteers and workers in order to minimize morbidity and mortality in the event of an influenza pandemic. The time t... more

Download (279)

View PDF (392)

Tracking aid for global health goals: a systematic comparison of four approaches applied to reproductive, maternal, newborn, and child health

Pitt C.; Grollman C.; Martinez-Alvarez M. et al The Lancet (2018) CC

Four initiatives have estimated the value of aid for reproductive, maternal, newborn, and child health (RMNCH): Countdown to 2015, the Institute for Health Metrics and Evaluation (IHME), the Muskoka Initiative, and the Organisation for Economic Co-operation and Development (OECD) policy marker. We... more

Download (515)

View PDF (504)

Ready to Save Lives: A Preparedness Toolkit for Sexual and Reproductive Health Care in Emergencies

IAWG on Reproductive Health in Crises, IPPF, JSI, et al. (2021) C1

The purpose of the toolkit is to bring together existing learning and guidance as a starting point for stakeholders to begin SRH preparedness work. Within the SRH sector the field of preparedness is relatively new and growing. More collective effort is required to further evaluate the impact of prep... more

External Link

Influenza Surveillance Among Children With Pneumonia Admitted to a District Hospital in Coastal Kenya, 2007–2010

Clayton O. Onyango, Regina Njeru, Sidi Kazungu et al. (2012) CC

J Infect Dis. (2012) 206 (suppl. 1): S61-S67 Influenza data gaps in sub-Saharan Africa include incidence, case fatality, seasonal patterns, and associations with prevalent disorders. The authors found that the burden of influenza was small during 2007–2010 in this paediatric hospital in Kenya. In... more

Download (248)

View PDF (277)

Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe

A. T. Makadzange; M. Higgins-Biddle; B. Chimukangara; et al. PLOS One (2015) CC

PLOS ONE | DOI:10.1371/journal.pone.0144057 December 14, 2015

Download (597)

View PDF (351)

Antibiotic Use for Sepsis in Neonates and Children: 2016 Evidence Update

Fuchs A., J. Bielickia, S. Mathur, et.al. World Health Organization (2016) C_WHO

Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.

Download (398)

View PDF (473)

Guideline: Adherence to antiretroviral therapy in adolescents and young adults (expanded version)

L. Fairlie; L. Jankelowitz; H. Ronald; et al. Southern African HIV Clinicians Society; Right to Care (Training Health Seriously) (2017) C2

Recommendations, resources and references A publication of the Southern African HIV Clinicians Society

Download (1277)

View PDF (1798)

Context Analysis: close-to-community health service providers in Kenya

M. Mireku,M. Kiruki, R. McCollum, et al. (2014) CC

External Link

The Chagas disease study landscape: A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data plat

Maguire, B.J.; Dahal, P.; Rashan, S. et al. PLOS Neglected Tropical Diseases (2021) CC

PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t... more

Download (4891)

View PDF (2460)

A Handbook for Integrating Sexual and Reproductive Health and Rights into HIV Programmes

Mary Nambao, Wezi Kaonga, Yusuf Ahmed, et al. SAfAIDS, Alliance Zambia (2011)